Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05490641 · ClinicalTrials.gov registry record · NA
Know and Own Your Movement-related Metrics Via Wearable Devices
A NA study, sponsored by The University of Texas at Arlington.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT05490641 is a NA study that has completed, run by The University of Texas at Arlington. The registered enrollment target is 60 participants.
The verdict
NCT05490641, a NA study, has completed, sponsored by The University of Texas at Arlington.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
This study aims to promote daily physical activity in cancer survivors who are at high risk for type 2 diabetes (T2D) by using a personalized biological-based feedback strategy. T2D is one of the most common co-occurring conditions in cancer survivors and can worsen cancer-related health outcomes, especially in those who are insufficiently active. The investigators hypothesize that seeing the immediate impacts of exercise on their biological status will motivate cancer survivors to exercise. The investigators will use real-time data from continuous glucose monitor to demonstrate the acute impact of physical activity and measure daily activity levels using wearable trackers. As wearable sensor technology is constantly advancing, this study is the first step to exploring how researchers can use wearable sensors to help people make a direct connection between their daily behaviors and health outcomes.
Interventions
- BEHAVIORAL Glucose-based biofeedback
- BEHAVIORAL Standard feedback
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2023-03-29 |
| Est. Completion | 2025-12-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05490641
The ClinicalTrials.gov registry entry for NCT05490641 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas at Arlington, which has 32 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Glucose-based biofeedback is the first listed.
NCT05490641 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05490641 about?
NCT05490641 is a clinical study titled "Know and Own Your Movement-related Metrics Via Wearable Devices". This study aims to promote daily physical activity in cancer survivors who are at high risk for type 2 diabetes (T2D) by using a personalized biological-based feedback strategy. T2D is one of the most common co-occurring conditions in cancer survivors and can worsen cancer-related health outcomes, e...
What is the current status of trial NCT05490641?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2023-03-29. Estimated completion is 2025-12-10.
What interventions are being tested in trial NCT05490641?
The interventions under investigation include: Glucose-based biofeedback (BEHAVIORAL), Standard feedback (BEHAVIORAL).
Who is sponsoring clinical trial NCT05490641?
This trial is sponsored by The University of Texas at Arlington, which has 32 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.